ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Beta Bionics, Inc.
20.14
-11.8500
-37.04%
盤後:
20.45
0.3101
+1.54%
19:59 EST
成交量:
829.11萬
成交額:
1.75億
市值:
8.87億
市盈率:
-11.38
高:
23.92
開:
22.75
低:
20.02
收:
31.99
52周最高:
32.71
52周最低:
8.89
股本:
4,402.46萬
流通股本:
2,370.20萬
量比:
11.86
換手率:
34.98%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.7690
每股收益(LYR):
-8.6026
淨資產收益率:
-47.52%
總資產收益率:
-20.08%
市淨率:
3.01
市盈率(LYR):
-2.34
資料載入中...
總覽
公司
新聞資訊
公告
Beta Bionics, Inc.盤中異動 下午盤急速下跌5.01%報26.75美元
市场透视
·
2025/11/14
異動解讀 | 貝塔生物電子股價盤中大漲19.07%,分析師上調目標價
异动解读
·
2025/10/29
異動解讀 | 貝塔生物電子股價盤前大漲14.87%,Leerink Partners上調目標價
异动解读
·
2025/10/29
美國研究綜述-ATI、GoDaddy、Lyft
路透中文
·
2025/10/29
Beta Bionics旗下輸注器械類產品獲FDA批准,註冊證號為K252770
动脉网
·
2025/10/27
Beta Bionics, Inc.2025財年第二財季實現淨利潤-16.87百萬美元,同比減少16.67%
市场透视
·
2025/08/03
異動解讀 | Beta Bionics股價盤中大漲10.98%,Truist證券上調目標價
异动解读
·
2025/07/30
異動解讀 | 業績超預期,Beta Bionics盤後大漲6.07%
异动解读
·
2025/07/30
Beta Bionics Inc 報告截至 6 月 30 日的季度業績 - 收益摘要
路透中文
·
2025/07/30
Beta Bionics Inc 預計每股虧損 45 美分 - 財報前瞻
路透中文
·
2025/07/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BBNX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":20.14,"timestamp":1767992400000,"preClose":31.99,"halted":0,"volume":8291062,"hourTrading":{"tag":"盘后","latestPrice":20.4501,"preClose":20.14,"latestTime":"19:59 EST","volume":526556,"amount":10663691.1408,"timestamp":1768006757984},"delay":0,"floatShares":23702000,"shares":44024631,"eps":-1.769,"marketStatus":"已收盤","change":-11.85,"latestTime":"01-09 16:00:00 EST","open":22.75,"high":23.92,"low":20.02,"amount":174777087.642222,"amplitude":0.121913,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.769,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":5,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":31.99,"preHourTrading":{"tag":"盘前","latestPrice":23,"preClose":31.99,"latestTime":"09:29 EST","volume":20188,"amount":506565.936464,"timestamp":1767968999107},"postHourTrading":{"tag":"盘后","latestPrice":20.4501,"preClose":20.14,"latestTime":"19:59 EST","volume":526556,"amount":10663691.1408,"timestamp":1768006757984},"volumeRatio":11.855061,"impliedVol":1.1464,"impliedVolPercentile":0.9},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":23702000,"roa":"-20.08%","roe":"-47.52%","lyrEps":-8.602584,"volumeRatio":11.855061,"shares":44024631,"dividePrice":0,"high":23.92,"amplitude":0.121913,"preClose":31.99,"low":20.02,"week52Low":8.89,"pbRate":"3.01","psRate":"10.01","week52High":32.71,"institutionHeld":0,"latestPrice":20.14,"eps":-1.769,"divideRate":0,"volume":8291062,"delay":0,"ttmEps":-1.769,"open":22.75,"prevYearClose":30.47,"prevWeekClose":29.25,"prevMonthClose":30.47,"prevQuarterClose":30.47,"fiveDayClose":29.25,"twentyDayClose":29.19,"sixtyDayClose":22.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2026-02-17","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771362000000,"name":null,"time":"盤後","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2026-01-08","symbol":"BBNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"BBNX","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-07-29","symbol":"BBNX","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1760936400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2026-01-08","current":-11.384963,"percent":0.033755,"low":-18.401318,"twenty":-16.104546,"median":-11.872473,"eighty":-8.849832,"high":-3.90273,"avg":-12.338168,"sd":3.327825,"marketCap":1386335630},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293},{"date":"2025-06-13","current":-11.90781,"twenty":-15.527784,"median":-10.843036,"eighty":-8.663027,"marketCap":845013916},{"date":"2025-06-20","current":-10.863051,"twenty":-15.401128,"median":-10.973025,"eighty":-8.671464,"marketCap":770874676},{"date":"2025-06-27","current":-9.158444,"twenty":-15.033515,"median":-10.853044,"eighty":-8.690985,"marketCap":649910652},{"date":"2025-07-03","current":-8.260318,"twenty":-14.588672,"median":-10.413035,"eighty":-8.668829,"marketCap":586176919},{"date":"2025-07-11","current":-8.284756,"twenty":-14.14074,"median":-9.690076,"eighty":-8.535817,"marketCap":587911170},{"date":"2025-07-18","current":-8.043423,"twenty":-13.87507,"median":-9.628891,"eighty":-8.433029,"marketCap":570785439},{"date":"2025-07-25","current":-8.816301,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"marketCap":625631134},{"date":"2025-08-01","current":-10.285126,"twenty":-12.797445,"median":-9.491423,"eighty":-8.48456,"marketCap":729863398},{"date":"2025-08-08","current":-9.243749,"twenty":-12.637058,"median":-9.506697,"eighty":-8.519369,"marketCap":655964186},{"date":"2025-08-15","current":-10.23612,"twenty":-12.367549,"median":-9.430326,"eighty":-8.524348,"marketCap":726385788},{"date":"2025-08-22","current":-10.346383,"twenty":-12.210773,"median":-9.506697,"eighty":-8.53478,"marketCap":734210411},{"date":"2025-08-29","current":-11.461269,"twenty":-12.163662,"median":-9.628891,"eighty":-8.548511,"marketCap":813326038},{"date":"2025-09-05","current":-12.312748,"twenty":-12.179108,"median":-9.681286,"eighty":-8.567484,"marketCap":873749512},{"date":"2025-09-12","current":-15.522638,"twenty":-12.446687,"median":-9.727683,"eighty":-8.641901,"marketCap":1101532967},{"date":"2025-09-19","current":-13.656808,"twenty":-13.735035,"median":-10.052347,"eighty":-8.661432,"marketCap":1001986381},{"date":"2025-09-26","current":-13.111721,"twenty":-13.639034,"median":-10.266749,"eighty":-8.666193,"marketCap":961993866},{"date":"2025-10-03","current":-12.140044,"twenty":-13.564381,"median":-10.319662,"eighty":-8.681485,"marketCap":890702861},{"date":"2025-10-10","current":-13.17097,"twenty":-13.533571,"median":-10.444395,"eighty":-8.70255,"marketCap":966340878},{"date":"2025-10-17","current":-12.222992,"twenty":-13.435219,"median":-10.631231,"eighty":-8.716023,"marketCap":896788678},{"date":"2025-10-24","current":-11.858613,"twenty":-13.293022,"median":-10.863051,"eighty":-8.739096,"marketCap":870054551},{"date":"2025-10-31","current":-15.145803,"twenty":-13.564381,"median":-11.055506,"eighty":-8.749568,"marketCap":1178979618},{"date":"2025-11-07","current":-14.161722,"twenty":-13.91523,"median":-11.228491,"eighty":-8.756685,"marketCap":1102376760},{"date":"2025-11-14","current":-14.840399,"twenty":-14.167423,"median":-11.440151,"eighty":-8.762559,"marketCap":1155206317},{"date":"2025-11-21","current":-16.062017,"twenty":-14.833302,"median":-11.540904,"eighty":-8.774755,"marketCap":1250299520},{"date":"2025-11-28","current":-17.724775,"twenty":-15.145803,"median":-11.576718,"eighty":-8.779642,"marketCap":1379731935},{"date":"2025-12-05","current":-16.966919,"twenty":-15.332439,"median":-11.635852,"eighty":-8.816301,"marketCap":1320738930},{"date":"2025-12-12","current":-16.57668,"twenty":-15.394651,"median":-11.66167,"eighty":-8.816301,"marketCap":1290361934},{"date":"2025-12-19","current":-16.435289,"twenty":-15.547354,"median":-11.719728,"eighty":-8.816301,"marketCap":1279355776},{"date":"2025-12-26","current":-17.583384,"twenty":-15.759893,"median":-11.773049,"eighty":-8.818649,"marketCap":1368725777},{"date":"2026-01-02","current":-17.232734,"twenty":-15.960216,"median":-11.858773,"eighty":-8.819236,"marketCap":1341430506},{"date":"2026-01-08","current":-17.80961,"twenty":-16.104546,"median":-11.872473,"eighty":-8.849832,"marketCap":1386335630}],"updateTime":1768015655861},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583183505","title":"Beta Bionics, Inc.盤中異動 下午盤急速下跌5.01%報26.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583183505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583183505?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 02:17","pubTimestamp":1763057853,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时17分,Beta Bionics, Inc.股票出现波动,股价急速跳水5.01%。截至发稿,该股报26.75美元/股,成交量18.1097万股,换手率0.41%,振幅8.43%。Beta Bionics, Inc.股票所在的医疗器械行业中,整体涨幅为0.56%。Beta Bionics, Inc.公司简介:Beta Bionics Inc 是一家商业化阶段的医疗器械公司,致力于设计、开发和商业化解决方案,通过利用自适应闭环算法简化和改善其疾病治疗,改善需要胰岛素的糖尿病患者 的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"1115917472","title":"異動解讀 | 貝塔生物電子股價盤中大漲19.07%,分析師上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1115917472","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115917472?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 22:41","pubTimestamp":1761748867,"startTime":"0","endTime":"0","summary":"周三盘中,贝塔生物电子(Beta Bionics,股票代码:BBNX)股价大涨19.07%,引起投资者广泛关注。\n\n消息面上,华尔街知名投资银行Leerink Partners对贝塔生物电子的前景看好,将该公司的目标股价从28美元上调至33美元。这一利好消息被认为是推动公司股价大幅上涨的主要原因。\n\n分析人士认为,Leerink Partners上调目标价反映了对贝塔生物电子未来发展的积极预期。这可能与公司在人工智能辅助糖尿病管理系统方面的创新和市场潜力有关。然而,投资者仍需密切关注公司未来的财务表现和产品开发进展,以评估这一股价上涨是否具有持续性。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"1153684762","title":"異動解讀 | 貝塔生物電子股價盤前大漲14.87%,Leerink Partners上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1153684762","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153684762?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 16:18","pubTimestamp":1761725922,"startTime":"0","endTime":"0","summary":"周三盘前,贝塔生物电子(Beta Bionics,股票代码:BBNX)股价大涨14.87%,引起投资者广泛关注。\n\n消息面上,华尔街知名投资银行Leerink Partners对贝塔生物电子的前景看好,将该公司的目标股价从28美元上调至33美元。这一利好消息可能是推动公司股价大幅上涨的主要原因。\n\n分析人士认为,Leerink Partners上调目标价反映了对贝塔生物电子未来发展的积极预期。这可能与公司在人工智能辅助糖尿病管理系统方面的创新和市场潜力有关。然而,投资者仍需密切关注公司未来的财务表现和产品开发进展,以评估这一股价上涨是否具有持续性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"2579260799","title":"美國研究綜述-ATI、GoDaddy、Lyft","url":"https://stock-news.laohu8.com/highlight/detail?id=2579260799","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579260799?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 15:24","pubTimestamp":1761722671,"startTime":"0","endTime":"0","summary":"美国研究综述-ATI、GoDaddy、Lyft路透10月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 ATI、GoDaddy 和 Lyft。要闻 * ATI Inc ATI.N:TD Cowen将目标价从95美元上调至120美元 * GoDaddy Inc GDDY.N:杰富瑞将目标价从170美元下调至150美元 * Lyft Inc LYFT.O:Roth MKM将目标价从19美元上调至25美元 * Visa Inc V.N:TD Cowen将目标价从407美元上调至416美元 * Whirlpool Corp WHR.N:加拿大皇家银行将目标价从 63 美元下调至 51 美元以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4T3WA0OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AWI","LU2357125470.USD","GLW","BBNX","NTLA","RNA","BOH","CZR","ABCB","ENPH","ECL","CRS","LU0348723411.USD","IVZ","ESQ","CAR","HRI","DHI","FTAI","LU2125909916.SGD","CLW","CAC","ATI","DORM","ARCC","AOS","CVLT","IQV","FSBC","ARQT","EFSC","AXTA","BMRC","GDDY","CAKE","CURB","BK4566","LU2089279066.USD","IE00BFXG0V08.USD","LU2125909759.SGD","INCY","LU2491050071.SGD","AMT","WGS","ET","SGXZ23171101.USD","BKNG","LU0006061336.USD","EW"],"gpt_icon":1},{"id":"2578269479","title":"Beta Bionics旗下輸注器械類產品獲FDA批准,註冊證號為K252770","url":"https://stock-news.laohu8.com/highlight/detail?id=2578269479","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578269479?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 10:01","pubTimestamp":1761530460,"startTime":"0","endTime":"0","summary":"产品名称:iLet ACE Pump,所属单位:Beta Bionics,产品类型:输注器械,产品详情:iLet ACE Pump是一款具备备用控制器功能的胰岛素泵,适用于 6 岁及以上糖尿病患者。iLet ACE Pump配备图形用户界面和警报功能,可实现与 iLet 输注系统及 iAGC 的交互操作。iLet ACE Pump搭载电机传动式输注机构,可独立驱动胰岛素从 “单独装入泵体的药筒” 中输出。审批机构:FDA,证件类型:二类,注册证编号:K252770,获批时间:2025-09-29","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510271008369743cf1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510271008369743cf1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2556846826","title":"Beta Bionics, Inc.2025財年第二財季實現淨利潤-16.87百萬美元,同比減少16.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556846826","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556846826?lang=zh_tw&edition=fundamental","pubTime":"2025-08-03 00:01","pubTimestamp":1754150479,"startTime":"0","endTime":"0","summary":"8月3日,Beta Bionics, Inc.公布财报,公告显示公司2025财年第二财季净利润为-16.87百万美元,同比减少16.67%;其中营业收入为23.24百万美元,同比增加54.42%,每股基本收益为-0.39美元。从资产负债表来看,Beta Bionics, Inc.总负债28.34百万美元,其中短期债务1.52百万美元,资产负债比为0.12,流动比率为0.15。机构评级:截至2025年8月3日,当前有9家机构对Beta Bionics, Inc.目标价做出预测,其中目标均价为23.67美元,其中最低目标价为17.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000154a6cf783e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000154a6cf783e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"gpt_icon":0},{"id":"1103250329","title":"異動解讀 | Beta Bionics股價盤中大漲10.98%,Truist證券上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1103250329","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103250329?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 22:46","pubTimestamp":1753886790,"startTime":"0","endTime":"0","summary":"周三盘中,Beta Bionics股价大幅上涨10.98%,引起投资者广泛关注。推动Beta Bionics股价上涨的主要因素是华尔街分析师的积极评价。据悉,Truist Securities分析师于当日将Beta Bionics的目标价从18美元上调至21美元,这一举动显著提振了投资者信心。分析人士认为,Truist Securities上调目标价反映了对Beta Bionics公司未来发展前景的看好。作为一家专注于开发人工胰腺系统的医疗科技公司,Beta Bionics在糖尿病管理领域具有创新优势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"1100799004","title":"異動解讀 | 業績超預期,Beta Bionics盤後大漲6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100799004","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100799004?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 05:06","pubTimestamp":1753823186,"startTime":"0","endTime":"0","summary":"周二盘后,Beta Bionics, Inc.股价大涨6.07%,主要受益于公司发布的季度业绩报告好于市场预期。根据公司公布的财报,截至6月30日的季度调整后每股亏损为39美分,优于分析师平均预期的45美分亏损。值得注意的是,尽管Beta Bionics股价在本季度下跌了3.9%,但华尔街分析师对公司前景仍保持乐观。目前,分析师对该公司股票的平均评级为\"买入\",12个月目标价中位数为26.00美元,较最新收盘价13.99美元高出约46.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"2555061237","title":"Beta Bionics Inc 報告截至 6 月 30 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2555061237","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555061237?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 05:01","pubTimestamp":1753822898,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc 报告截至 6 月 30 日的季度业绩 - 收益摘要Beta Bionics Inc BBNX.OQ 公布了截至 6 月 30 日的季度调整后每股亏损 39 美分。Beta Bionics Inc公布的本季度每股收益为亏损39美分。该公司当季亏损 1687 万美元。Beta Bionics Inc 的股价本季度下跌了 3.9%。华尔街对 Beta Bionics 公司 12 个月目标价的中位数为 26.00 美元,比上次收盘价 13.99 美元高出约 46.2%。本摘要由 LSEG 7 月 29 日 09:01 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nL4T3TQ26L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2554677794","title":"Beta Bionics Inc 預計每股虧損 45 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2554677794","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554677794?lang=zh_tw&edition=fundamental","pubTime":"2025-07-26 04:07","pubTimestamp":1753474029,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc 预计每股亏损 45 美分 - 财报前瞻Beta Bionics Inc BBNX.OQ BBNX.O 预计将于7月29日公布截至2025年6月30日的财报。根据LSEG的数据,9位分析师的平均预期是,这家总部位于加利福尼亚州欧文市的公司预计将实现1968.4万美元的营收。LSEG 的分析师平均预计 Beta Bionics 公司每股亏损 45 美分。华尔街对 Beta Bionics 公司 12 个月目标价的中位数为 26.00 美元,比上次收盘价 14.43 美元高出约 44.5%。7月25日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nL4T3TM1J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}